These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4132195)

  • 21. Low catalase activity in blood is associated with the diabetes caused by alloxan.
    Takemoto K; Tanaka M; Iwata H; Nishihara R; Ishihara K; Wang DH; Ogino K; Taniuchi K; Masuoka N
    Clin Chim Acta; 2009 Sep; 407(1-2):43-6. PubMed ID: 19563792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Red cell glycolytic intermediates in diabetic patients.
    Tegos C; Beutler E
    J Lab Clin Med; 1980 Jul; 96(1):85-9. PubMed ID: 7391659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antioxidant enzyme activity in the erythrocytes of rats with alloxan diabetes].
    Terekhina NA; Khorobrykh OIu; Khorobrykh TP
    Patol Fiziol Eksp Ter; 1998; (4):25-6. PubMed ID: 9951299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood glutathione and its relation with haemoglobin and red blood cell count in tuberculosis, leprosy and diabetes. II.
    PANSE MV; GOKHALE SK
    Indian J Med Res; 1958 Mar; 46(2):159-70. PubMed ID: 13549005
    [No Abstract]   [Full Text] [Related]  

  • 25. [Formate incubation of red blood cells from glucose-6-phosphate-dehydrogenase-deficient patients].
    Grieger M; Schippel W; Siems W; Leppin K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):704-15. PubMed ID: 6198254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effect of formate on GSH concentration and Heinz body formation: a preliminary model study.
    Rapoport S; Müller M; Siems W; Grieger M
    Haematologia (Budap); 1974; 8(1-4):127-34. PubMed ID: 4142616
    [No Abstract]   [Full Text] [Related]  

  • 27. [Regulation of 2,3-diphosphoglycerate in erythrocytes of diabetic patients].
    Standl E; Kolb H; Mehnert H
    Verh Dtsch Ges Inn Med; 1973; 79():1191-4. PubMed ID: 4790134
    [No Abstract]   [Full Text] [Related]  

  • 28. Erythrocyte antioxidant enzymes in patients with cataract.
    Chandrasena LG; Chackrewarthy S; Perera PT; de Silva D
    Ann Clin Lab Sci; 2006; 36(2):201-4. PubMed ID: 16682518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The contribution of normal and pathologic erythrocytes to blood rheology.
    La Celle PL; Weed RI
    Prog Hematol; 1971; 7(0):1-31. PubMed ID: 4950833
    [No Abstract]   [Full Text] [Related]  

  • 30. [Some metabolic peculiarities of the neonatal red cell].
    Madec Y; Dubin JC; Bernard S; Gillot F
    Arch Fr Pediatr; 1967 Apr; 24(4):433-44. PubMed ID: 6077790
    [No Abstract]   [Full Text] [Related]  

  • 31. [Interrelation of diabetes mellitus, atherosclerosis and ischemic heart disease].
    Bodnar PN; Donish RM; Pristupiuk AM
    Ter Arkh; 1984; 56(10):88-92. PubMed ID: 6523367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antioxidant status and levels of different vitamins determined by high performance liquid chromatography in diabetic subjects with multiple complications.
    Merzouk S; Hichami A; Madani S; Merzouk H; Berrouiguet AY; Prost J; Moutairou K; Chabane-Sari N; Khan NA
    Gen Physiol Biophys; 2003 Mar; 22(1):15-27. PubMed ID: 12870698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Erythrocyte glycolysis in normal & diabetic subjects & its relation to acetylcholinesterase activity].
    GHIOTTO G; DE SANDRE G
    Arch Sci Med (Torino); 1958 Aug; 106(2):201-14. PubMed ID: 13560229
    [No Abstract]   [Full Text] [Related]  

  • 34. [Research on Heinz bodies in erythrocytes of newborn. III. Catalase activity in blood of newborn].
    KUNZER W; SCHUTZ E; AMBS E
    Z Kinderheilkd; 1955; 76(1):48-57. PubMed ID: 14397585
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of pyridoxine alpha-ketoglutarate on blood glucose and lactate in type I and II diabetics.
    Passariello N; Fici F; Giugliano D; Ceriello A; Dello Russo P; Sgambato S
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):252-6. PubMed ID: 6862730
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolic exhaustion and osmotic fragility in erythrocytes of prediabetic and diabetic women.
    Ramasso JC; Foglia VG
    Acta Physiol Lat Am; 1969; 19(2):111-5. PubMed ID: 5362850
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in erythrocyte glucose-6-phosphate dehydrogenase (G6PD) and reduced glutathione (GSH) activities in the development of senile and diabetic cataracts.
    Chandrasena LG; De Silva LD; De Silva KI; Dissanayaka P; Peiris H
    Southeast Asian J Trop Med Public Health; 2008 Jul; 39(4):731-6. PubMed ID: 19058613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
    Vijayalingam S; Parthiban A; Shanmugasundaram KR; Mohan V
    Diabet Med; 1996 Aug; 13(8):715-9. PubMed ID: 8862945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oxidative damage of mice erythrocytes infected with Plasmodium berghei].
    Grieger M; Siems W; Müller M; Grinberg L; Leppin K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(4):581-93. PubMed ID: 6196273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of glutathione levels and Heinz body formation to irreversibly sickled cells in sickle cell anemia.
    Wetterstroem N; Brewer GJ; Warth JA; Mitchinson A; Near K
    J Lab Clin Med; 1984 Apr; 103(4):589-96. PubMed ID: 6699474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.